Cover Image
市場調查報告書

糖尿病的美國市場

US Diabetes Market Report: 2016 - 2020

出版商 IMARC Services Pvt. Ltd. 商品編碼 359384
出版日期 內容資訊 英文 44 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
糖尿病的美國市場 US Diabetes Market Report: 2016 - 2020
出版日期: 2016年05月17日 內容資訊: 英文 44 Pages
簡介

本報告提供美國的糖尿病市場相關調查分析,現在、未來趨勢 (盛行率、人口統計、診斷、治療) 相關驗證,流行病學,市場趨勢,治療結構,競爭結構,市場預測等系統性資訊。

第1章 調查手法

第2章 摘要整理

第3章 糖尿病概要

  • 所謂糖尿病
  • 糖尿病的診斷和治療
  • 糖尿病的併發症

第4章 促進美國的糖尿病市場的主要原因

第5章 美國的糖尿病的流行病學

  • 糖尿病人口和盛行率
  • 人口和盛行率:各糖尿病類型 (第一型、第二型)
  • 人口和盛行率:各地區
  • 人口和盛行率:性別
  • 人口和盛行率:各年齡層

第6章 美國的糖尿病市場

  • 過去的市場趨勢
  • 市場預測
  • 市場明細:各市場區隔
  • 美國的口服抗糖尿病藥物市場
  • 美國的胰島素市場

圖表

目錄
Product Code: SRP00116DN

IMARC's new report "US Diabetes Market Report: 2016 - 2020 " provides an analytical and statistical insight into the US diabetes market. The report provides both current and future trends in the prevalence, demographical breakup, diagnosis and treatment of diabetes in the United States. The research study serves as an exceptional tool to understand the epidemiology, market trends, therapeutic structure, competitive structure and the outlook of the US diabetes market. This report can serve as an excellent guide for investors, researchers, consultants, marketing strategists and all those who are planning to foray into the US diabetes market in any form.

What we have achieved in this report:

Comprehensive situation analysis of the US diabetes epidemiology and its dynamics:

Focus of the Analysis:

  • Historical, current and future prevalence of diabetes in US
  • Historical, current and future prevalence of type-1 and type-2 diabetes in US
  • Historical, current and future prevalence of diabetes in the urban and rural regions in US
  • Historical, current and future prevalence of diabetes among males and females in US
  • Historical, current and future prevalence of diabetes among various age groups in US
  • Historical, current and future diagnosis rates for diabetes in US
  • Historical, current and future drug treatment rates for diabetes in US

Comprehensive situation analysis of the US Oral Antidiabetics market and its dynamics:

Focus of the Analysis:

  • Performance of the Oral Antidiabetics market in US
  • Performance of key classes
  • Performance of key players
  • Market outlook

Comprehensive situation analysis of the US Insulin market and its dynamics:

Focus of the Analysis:

  • Performance of the Insulin market in US
  • Performance of key classes
  • Performance of key players
  • Market outlook

Table of Contents

1 Research Methodology

2 Executive Summary

3 Diabetes Disease Overview

  • 3.1 What is Diabetes?
  • 3.2 Diabetes Diagnosis and Treatment
    • 3.2.1 Diagnosis
    • 3.2.2 Treatment
  • 3.3 Diabetes Complications

4 Key Factors Driving the Diabetes Market in US

5 US Diabetes Epidemiology

  • 5.1 Diabetes Population and Prevalence Rates
  • 5.2 Population and Prevalence Rates by Diabetes Type (Type-1 and Type-2)
  • 5.3 Population and Prevalence Rates by Region
  • 5.4 Population and Prevalence Rates by Gender
  • 5.5 Population and Prevalence Rates by Age Group

6 US Diabetes Market

  • 6.1 Historical Market Trends
  • 6.2 Market Outlook
  • 6.3 Market Breakup by Segment
  • 6.4 US Oral Antidiabetics Market
    • 6.4.1 Historical Market Trends
    • 6.4.2 Market Breakup by Class
    • 6.4.3 Market Shares of Key Players
    • 6.4.4 Market Outlook
  • 6.5 US Insulin Market
    • 6.5.1 Historical Market Trends
    • 6.5.2 Market Breakup by Class
    • 6.5.3 Market Shares of Key Players
    • 6.5.4 Market Outlook

List of Figures

  • Figure 3 1: The impact of Diabetes in the Human Body
  • Figure 3 2: Diabetes Complications
  • Figure 4 1: Global: Breakup of Diabetes Patients by Region, (in %) 2015 & 2035
  • Figure 4 2: US: Overweight & Obese Population* (in Million), 2010, 2015 & 2020
  • Figure 4 3: Body Mass Index and Relative risk of Type-2 Diabetes
  • Figure 4 4: US: Breakup of Total Population by Age Groups (0-14, 15-64 & 65+), (in %)
  • Figure 4 5: US: Diabetes Prevalence By Age Groups, (in %)
  • Figure 5 1: US: Total Number of Diabetes Patients* (in 000), 2008-2015
  • Figure 5 2: US: Total Number of Diabetes Patients* Forecast (in 000), 2016-2020
  • Figure 5 3: US (Type1 & Type2): Total Number of Diabetes Patients* (in 000), 2008- 2015
  • Figure 5 4: US (Type1 & Type2): Total Number of Diabetes Patients* (in 000),2016-2020
  • Figure 5 5: US (Urban & Rural): Total Number of Diabetes Patients* (in 000), 2008 -2015
  • Figure 5 6: US (Urban & Rural): Total Number of Diabetes Patients* (in 000), 2016 - 2020
  • Figure 5 7: US (Male & Female): Total Number of Diabetes Patients* (in 000), 2008 - 2015
  • Figure 5 8: US (Male & Female): Total Number of Diabetes Patients* (in 000), 2016 - 2020
  • Figure 5 9: US: Total Number of Diabetes Patients by Age Group (20-39), (40-59) & (60-79) (in 000), 2008 - 2015
  • Figure 5 10: US: Total Number of Diabetes Patients by Age Group (20-39), (40-59) & (60-79) (in 000), 2016 - 2020
  • Figure 6 1: US: Diabetes Drugs Market (in Million US$), 2008 - 2015
  • Figure 6 2: US: Diabetes Drug Market Forecast (in Million US$), 2016 - 2020
  • Figure 6 3: US: Diabetes Drugs Market: Breakup of Insulin and Oral Antidiabetics (in %), 2008- 2015
  • Figure 6 4: US: Diabetes Drugs Market Forecast: Breakup of Insulin and Oral Antidiabetics (in %), 2016 - 2020
  • Figure 6 5: US: Oral Antidiabetics Market: (in Million US$), 2008 - 2015
  • Figure 6 6: US: Oral Antidiabetics Market: Sales Share of Key Classes (in %), 2008 & 2015
  • Figure 6 7: US: Oral Anti-diabetics Market: Sales Share of Key Players (in %)
  • Figure 6 8: US: Oral Antidiabetics Market: (in Million US$), 2016 - 2020
  • Figure 6 9: US: Oral Antidiabetics Market: Sales Share of Key Classes (in %), 2016 & 2020
  • Figure 6 10: US: Insulin Market, (in Million US$), 2008 - 2015
  • Figure 6 11: US: Breakup of Insulin Market by Class (in %)
  • Figure 6 12: US: Insulin Market: Sales Share of Key Players (in %)
  • Figure 6 13: US: Insulin Market Forecast (in Million US$), 2016 - 2020

List of Tables

  • Table 3 1: Diagnosis of Diabetes
  • Table 4 1: Global: Diabetes Population Breakup by Country (in 000's), 2015 & 2035
  • Table 4 2: US: Overweight &Obesity Statistics, 2010, 2015 & 2020
  • Table 4 3: US: Breakup of Total Population by Age Groups (0-14, 15-64 & 65+), (in Million)
  • Table 5 1: US: Total Prevalence & Number of Diabetes Patients*, 2008, 2015 & 2020
  • Table 5 2: US (Type1 & Type2): Total Prevalence & Number of Diabetes Patients, 2008, 2015 & 2020
  • Table 5 3: US (Urban & Rural): Total Prevalence & Number of Diabetes Patients, 2008, 2015 & 2020
  • Table 5 4: US (Male & Female): Total Prevalence & Number of Diabetes Patients, 2008, 2015 & 2020
  • Table 5 5: Total Prevalence & Number of Diabetes Patients by Age Group (20-39), (40-59) & (60-79) (In Millions), 2008, 2015 & 2020
Back to Top